Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype that is devoid of the expression of the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) (Cortes et al., 2022; Jia et al., 2017). This evidence concerns the gene ESR1 and triple-negative breast carcinoma.